Lp (a) LP2757Recalls & reported problems
Randox Laboratories Limited · Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein(a) in human serum or plasma. · Class 2
All models of Lp (a) (2)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier, 1 still open.
1 other recall cover devices cleared under the same FDA submission (K011568); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- Dec 20, 2024Open, Classified
Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.
Z-1018-2025 · Root cause: No Marketing Application · Recall details · FDA record ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K011568. One submission often covers many models, so check the product and lot details in each record.
- Z-1017-2025 · Dec 20, 2024 · Open, ClassifiedRandox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403
Other Lipoprotein, Low-Density, Antigen, Antiserum, Control devices
- Lp (a) LP3403Randox Laboratories Limited · Lipoprotein, Low-Density, Antigen, Antiserum, Control1 recall0 reports
- Tina-quant Lipoprotein (a) Gen.2 08106126190Roche Diagnostics GmbH · LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL28 reports
- Tinaquant Lipoprotein a Gen.2 5852633190Roche Diagnostics GmbH · LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL2 reports
- Tinaquant Lipoprotein a Gen.2 5852625190Roche Diagnostics GmbH · LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page